 IRVINE, Calif., Feb. 23, 2021 GLOBE NEWSWIRE -- Oncocyte Corporation NYSE American: OCX, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, has been approved for listing on the Nasdaq Global Market. The Companys shares will continue to trade under its current symbol, OCX, with trading on Nasdaq expected to commence at the open of market on Monday, March 8, 2021. Oncocytes shares will continue to trade on the NYSE American Exchange until the close of trading on Friday, March 5, 2021. 